<VariationArchive VariationID="215144" VariationName="NM_032861.4(SERAC1):c.1347_1350dup (p.Val451fs)" VariationType="Duplication" Accession="VCV000215144" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2015-10-11" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="211210" VariationID="215144">
      <GeneList>
        <Gene Symbol="SERAC1" FullName="serine active site containing 1" GeneID="84947" HGNC_ID="HGNC:21061" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="158109519" stop="158168262" display_start="158109519" display_stop="158168262" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="158530535" stop="158589311" display_start="158530535" display_stop="158589311" Strand="-" />
          </Location>
          <OMIM>614725</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_032861.4(SERAC1):c.1347_1350dup (p.Val451fs)</Name>
      <CanonicalSPDI>NC_000006.12:158117779:AGATA:AGATAGATA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="158117779" stop="158117780" display_start="158117779" display_stop="158117780" variantLength="4" positionVCF="158117779" referenceAlleleVCF="C" alternateAlleleVCF="CAGAT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="158538811" stop="158538812" display_start="158538811" display_stop="158538812" variantLength="4" positionVCF="158538811" referenceAlleleVCF="C" alternateAlleleVCF="CAGAT" />
      </Location>
      <ProteinChange>V451fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.158538813_158538816dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.158538813_158538816dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.158117781_158117784dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.158117781_158117784dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032889.1" sequenceAccession="NG_032889" sequenceVersion="1" change="g.55498_55501dup">
            <Expression>NG_032889.1:g.55498_55501dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032861.4" sequenceAccession="NM_032861" sequenceVersion="4" change="c.1347_1350dup" MANESelect="true">
            <Expression>NM_032861.4:c.1347_1350dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116250.3" sequenceAccession="NP_116250" sequenceVersion="3" change="p.Val451fs">
            <Expression>NP_116250.3:p.Val451fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032861.3" sequenceAccession="NM_032861" sequenceVersion="3" change="c.1347_1350dupATCT">
            <Expression>NM_032861.3:c.1347_1350dupATCT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA323856" DB="ClinGen" />
        <XRef Type="rs" ID="780275814" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_032861.4(SERAC1):c.1347_1350dup (p.Val451fs) AND not provided" Accession="RCV000199325" Version="8">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-02-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_032861.4(SERAC1):c.1347_1350dup (p.Val451fs) AND 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome" Accession="RCV003532048" Version="1">
        <ClassifiedConditionList TraitSetID="8743">
          <ClassifiedCondition DB="MedGen" ID="C4040739">3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-25" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-10-11" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22683713</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29686941</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8743" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17318" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MEGDEL syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome</ElementValue>
                <XRef ID="MONDO:0013875" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-METHYLGLUTACONIC ACIDURIA, TYPE VI</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MEGDEL</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MGCA6</ElementValue>
                <XRef Type="MIM" ID="614739" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of SERAC1 deficiency comprises MEGD(H)EL syndrome (3-methylglutaconic aciduria with deafness-dystonia, [hepatopathy], encephalopathy, and Leigh-like syndrome), juvenile-onset complicated hereditary spastic paraplegia (in 1 consanguineous family), and adult-onset generalized dystonia (in 1 adult male). MEGD(H)EL syndrome is characterized in neonates by hypoglycemia and a sepsis-like clinical picture for which no infectious agent can be found. During the first year of life feeding problems, failure to thrive, and/or truncal hypotonia become evident; many infants experience (transient) liver involvement ranging from undulating transaminases to prolonged hyperbilirubinemia and near-fatal liver failure. By age two years progressive deafness, dystonia, and spasticity prevent further psychomotor development and/or result in loss of acquired skills. Affected children are completely dependent on care for all activities of daily living; speech is absent.</Attribute>
                <XRef ID="NBK195853" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12963" />
                <XRef ID="12963" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24741715</ID>
                <ID Source="BookShelf">NBK195853</ID>
              </Citation>
              <XRef ID="352328" DB="Orphanet" />
              <XRef ID="C4040739" DB="MedGen" />
              <XRef ID="MONDO:0013875" DB="MONDO" />
              <XRef Type="MIM" ID="614739" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="467346" SubmissionDate="2019-01-29" DateLastUpdated="2015-10-11" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="GDX:57201|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000252252" DateUpdated="2015-10-11" DateCreated="2015-10-11" Type="SCV" Version="6" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-02-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1347_1350dupATCT variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.1347_1350dupATCT variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The c.1347_1350dupATCT variant causes a frameshift starting with codon Valine 451, changes this amino acid to an Isoleucine residue and creates a premature Stop codon at position 5 of the new reading frame, denoted p.Val451IlefsX5. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. We interpret this variant as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SERAC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="AGATAGAT" referenceAllele="AGAT" start="158538811" stop="158538812" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032861.3:c.1347_1350dupATCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7977231" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4807329|MedGen:C3553597" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004290383" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22683713</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29686941</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val451Ilefs*5) in the SERAC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SERAC1 are known to be pathogenic (PMID: 22683713). This variant is present in population databases (rs780275814, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with 3-methylglutaconic aciduria (PMID: 29686941). ClinVar contains an entry for this variant (Variation ID: 215144). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SERAC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.158538811_158538812insAGAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553597" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7977231" TraitType="Disease" MappingType="XRef" MappingValue="C3553597" MappingRef="MedGen">
        <MedGen CUI="C4040739" Name="3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="467346" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002020064</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

